Education

College or University:

Emory University, Atlanta, GA Biology 1971-72  Temple University, Philadelphia, PA, Honors College (Pre-Med) 1972-74

Graduate School:

University of Southern California, Los Angeles, CA, MSEd 1982-87 Education, 1987  Georgetown School of Bioethics, Bethesda, MD, Medical Bioethics 1988-89

Medical School:

Philadelphia College of Osteopathic Medicine, Philadelphia, PA, D.O. 1974-78 Medicine, 1978

Biography

Dr. David Baron is currently a Professor of Psychiatry at the Keck School of Medicine at University of Southern California, Director, and Global Center for Exercise, Psychiatry and Sports at USC and Adjunct Professor at the USC School of Cinema-Television. Dr. Baron is currently working on cutting edge research on Traumatic Brain Injuries funded by the NFL.

Research Interest

• Adult ADHD Neuropsychiatric
• Head trauma in sports,
• Depression in Athletes
• Global Mental Health Literacy
• Genetics of Bipolar Disorder
• PTSD in returning vets

Professional Activities:

Publications

1. Baron, D., “Emergency Psychiatry”, Osteopathic Annuals 1980; 8; 5-8
2. Johnson, W., Baron, D., MacGregor, H., “ Changes in Student Attitudes about a Psychiatric Career”, Journal of Psychiatric Education 6(4):236-245, 1982
3. Baron, D., “Portable Nocturnal Penile Tumescence Monitoring in Evaluating Impotence”, J Am Osteopath Assoc.;82(9):678,1983 May
4. Procci, W., Moss, H., Boyd, J., Baron, D., “Consecutive-Night Reliability of Portable Nocturnal Penile Tumescence Monitoring”, Archives Sexual Behavior 12(4); 307-16, 1983
5. Baron, DA, Shea S, White K., “The Dexamethasone Suppression Test: some Limitations in the General Hospital Setting”, J Am Osteopath Assoc. 83(7):505-8, 1984
6. Baron, D., Shea, S., White, K., et al. “ Dexamethasone Suppression Test in General Hospital Psychiatry”, JAOA 83(3), 1984
7. Gray, G., Baron, D., Herman, J., “Important of Medicine Anthropology in Clinical Psychiatry”, The American Journal of Psychiatry 142(2); 275, 1985
8. Baron, D., Nagy, R., “Impotency in Diabetic Men: Medical and Psychiatric Considerations”, JACN 1(4); 11-12, 1987
9. Baron, D., “Immunologic Mechanisms in Psychiatric Disorders”, JACN 1(7); 11-13, 1987
10. Baron, D., “Emotional Aspects of Chronic Disease”, JAOA 87(6); 437-440, 1987
11. Eth, S., Baron, D., Pynoos, R., “Death Notifications”, Bull Am. Acad. Psychiatry Law 15(3); 275-81, 1987
12. Baron, D., Hueholt, T.M., “Physicians and Healthcare Workers, Reactions to Caring for AIDS Patients”, Medical Aspects of Human Sexuality 42-48, 1987
13. Boyd, S., Feinberg, S., Skinner, D.G., Lieskovsky, G., Baron, D., Richardson, J., “Quality of Life Survey of Urinary Diversion Patients: Comparison of Ileal Conduits Versus Continent Kock lleal Reservoirs”, Journal of Urology. 138(6); 1386-9, 1987
14. Baron, D., Nagy, R., “The Amobarbital interview in a General Hospital Setting, Friend or Foe: A Case Report”, General Hospital Psychiatry 10(3); 220-222, 1988
15. Simpson, G., Pi, E., Gross, L., Baron, D., “Plasma Levels of Therapeutic Response with Trimipramine Treatment of Endogenous Derpression”, Journal Clinical Psychiatry 49(3); 113-116, 1988
16. Schmidt, P.J., Baron, D., and Rubinow, D., “Premenstrual Syndromes: Diagnoses, Etiology, and Treatment”, Mediguide to Ob/Gyn 6; 1-4, 1988
17. Levine, S., Anderson, D., Bystritsky, A., Baron, D., “A Report of Eight HIV-Seropositive Patients with Major Depression Responding to Fluoxetine”, Journal Acquired Immune Deficiency Syndrome 3(11); 1074-1077, 1990
18. Levine, S.H., Bystritsky, A., Baron, D., Jones, LD, “Group Psychotherapy for HIV Seropositive patients with Major Depression” American Journal of Psychotherapy; 45(3); 413-24, 1991
19. Baron, D., “Seasonal Anxiety Disorder: “Factor or Fantasy”, JACN 5; 4-5, 1991
20. Kneller, G., Baron, D., Garrigan, J., “Post-Traumatic Stress Disordered in Special Forces Vietnam Veterans: A Limbic Dyscontrol Hypothesis”, JACN 5; 6-9, 1991
21. Baron, D., Samuel, W., “Physical, Psychological and Social Correlates of Patients with Asthma”, JAOA 91(8); 737-744, 1991
22. Baron, D., “Dementia in Patients with the Acquired Immunodeficiency Syndrome”, JAOA 91(8); 772-776, 1991
23. Paciotti, G.F., Baron, D., et al., “Novel Enzyme Immunoassays for the Detection of the Cytokines Interleukin-1 and Interleukin-2 in the Circulation of Normal Subjects: 24 Hour Profiles”, Prog. Neuroendocrin. Immunol”, 5; 21-30, 1992
24. Brown, T.M. and Baron, D., “Anxiety Disorders Seen in Primary Care”, JAOA 92(1); 95-101, 1992
25. Baron, D.A., Hardie, T.L., & Baron, S.H., Possible Associated of interleukin-2 treatment with depression and Suicide, JAOA 93(7); 799-800, 1993
26. Smyser, C.H. & Baron, D.A., “Hypontizability, Absorption and Subscales of the Dissociation Experiences Scale in Nonclinical Population”, Dissociation 6(1); 42-46, 1993
27. Baron, D.A., Hardie, T., & Baron, S.H., “Diagnosis and Treatment of Depression in Primary Care”, JAOA 94(2); 172-176, 1994
28. Baron, S.H., Hardie, T., & Baron, D., “Behavioral Effects of Smoking Cessation on an Adolescent, In-Patient, Psychiatric Unit”, JACN 8(1); 3-6, 1994
29. Hardie, T., Baron, D., & Baron. S., “Recognition and Diagnosis of Depression and Anxiety in the Primary Care Setting”, JAOA 95(12); 52-57, 1995
30. Schmidt, P., Rubinow, D., Gindoff, P., & Baron, D., “Basal and Stimulated Gonadotropin Levels in Perimenopause”, American Journal of Obstetrics and Gynecology 197; 643-650, 1996
31. Baron, D., Hardie, T., Baron, S., “Pharmacoeconmic issues in Treating Depression”, JAOA 2(97) S1-S5, 1997
32. Hardie, T., Baron, D., & Baron, S., “Diagnosis and Treatment of Dysthymia in Primary Care”, JAOA 97(2); S1-S, 1997
33. Baron, D., and Hardie, T., “Pharmacologic Treatment of Anxiety and Depression in Primary Care”, JAOA 97(5); S14-S18, 1997
34. Tilman, S., Morris, L., Hardie T., & Baron, D., “Anxiety in Childhood: An Overview”, JAOA 97(5); S2-S7, 1997
35. Copel, L. & Baron, D., “Recognition and Treatment of Partner Abuse”, JAOA 97(5); S7-S13, 1997
36. Leventhal, J. & Baron, D., “Menopause and Mood: A Practical Review”, JAOA 97(5); S14-S20, 1997
37. Baron D, Silberman AJ, D’Alonzo GE, The Sobering Effects of Binge Drinking, J Am Osteopath Assoc, 98(10):530-1, 1998
38. Baron, D. A., Hardie, T., Leventhal, J. L., & Della Badia, C. R., Timing of hysterectomy surgery during the menstrual cycle--impact of menstrual cycle phase on rate of complications: preliminary study. J Am Osteopath Assoc, 99(1):25-27, 1999
39. Baron, D., “Focus: Addiction and Substance Abuse”, Like father, Like Son: Temple Psychiatrists Discover Link Between Substance Abuse in Sons and Fathers, Hospital & Healthcare News; June 2000
40. Sholevar, E., Baron, D & Hardie, T. “Treatment of Childhood-Onset Schizophrenia with Olanzapine”, J. Child & Adolescent Psychopharmacology, 10(2):69-78, 2000
41. Moss, H.B., Baron, D.A., Hardie, T.L., Vanyukov, M. M., Preadolescent children of substance-dependent fathers with antisocial personality disorder: psychiatric disorders and problem behaviors. Am J Addict, 10(3):269-278, 2001
42. Kochhar, S., Nwokike J.N., Jankowitz, B., Sholevar, E.H., Abed, T., Baron, D.A., Olanzapine overdose: a pediatric case report, J Child Adolesc Psychopharmacol, 12(4):351-353, 2002
43. Moss, H., Lynch, K., Hardie, T. & Baron, D., “Family Functioning and Peer Affiliation in Children of Fathers With Antisocial Personality Disorder and Substance Dependence: Associations with Problem Behaviors”, Am. J. Psychiatry, 7-614, 2002
44. Baron, D, Hay, Donald P., & Easom, Hilary M., “Treating Patients in Primary Care: The Impact of  Mood, Behavior, and Thought Disturbances,” The Journal of the American Osteopathic Association, Vol. 103, No. 7, July 2003
45. Baron, D., “Case Histories for Understanding Depression in Primary Care,” The Journal of American Osteopathic Association. 103(8), 16-18, 2003
46. Baron, D., Lipkovich, I., Ahmed, S., Ahl, J., Bruce, K. J., Rotelli, M., Dose Changes in a Flexible Dose Study: Determinants Consequences, American Osteopathic Association Annual Convention (AOA) October 12-15, 2003 / New Orleans
47. Baron, D and Bizamcer, AN, The Relationship of ADHD, Its Treatment and Substance Use. Behavioral Health Management, 24(4): S1-S4, 2004
48. Salaam K, Carr J, Grewal H, Sholevar E, Baron D. “Untreated Trichotillomania and Trigophagia: Surgical Emergency in a Teen-Aged Gril” Psychosomatics 46(4), 362-6, July-August 2005
49. Antia S, Sholevar E, Baron D. “Overdoses and Ingestions of Second-generation Antipsychotics in Children and Adolescents” Journal of Child and Adolescent Psychopharmacology, 15(6): 970-985, 2005
50. McDuff DR, Baron, D., Substance use in athletics: a sports psychiatry perspective, 24(4):885-97, Oct 2005
51. Lipkovich I, Baron D, Houston J, Ahl J, Rotelli M, Flexible-dose clinical trials: predictors and outcomes of antipsychotic dose adjustments, J Clin Psychopharmacol, 25(4):381-6, 2005
52. Raffa, RB, Baron, DA, Tallarida RJ, Schild (apparent pA2) analysis of a kappa-opioid antagonist in Planaria. Eur J Pharmacol 540(1-3):200-1, 2006
53. Rawls, SM, Rodriguez T, Baron DA, Raffia RB, A nitric oxide synthase inhibitor (L-NAME) attenuates abstinence-induced withdrawal from both cocaine and a cannabinoid agonist (WIN 55212-2) in Planaria. Brain Res 1(82-7), 2006
54. Carr JR, Sholevar EH, Baron DA, Trichotillomania and trichobezoar: a clinical practice insight with report of illustrative case, J Am Osteopath Assoc, 106(11):647-52, 2006
55. Martin, D., Baron, D., Gold, M. A review of Performance-Enhancing Drugs in Professional Sports and Their Spread to Amateur Athletes, Adolescents, and Other At-Risk Populations. Journal of Addictive Diseases, 25(1), 5-15 2006
56. Baron, D., Martin, D.M., Magd, S.A., Doping in sports and its spread to at-risk populations: An international review. World Psychiatry. 6(2):118-23, June 2007
57. Baron, D. How the AACDP Helped me Professionally and Personally, Academic Psychiatry, 31(2):99-100, March-Apr 2007
58. E.H. Sholevar, D.A. Baron, Hair we go! Absorbing insights on trichotillomania with trichobezoar, Psychiatry Vol 9 Issue 3/2007
59. Hans-Jürgen Möller (Section Chairman); Ulrik Malt (Section Secretary); Bernd Saletu Section Treasurer), A. Carlo Altamura, David S. Baldwin, David Baron, et al. Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: Consensus Statement
60. Ilya Lipkovich, David H Adams, Craig Mallinckrodt, Doug Faries, David A Baron and John P Houston: Evaluating dose response from flexible dose clinical trials. BMC Psychiatry, 8(1):P.3 2008
61. Nadeem H. Bhanji, David A. Baron, Benjamin W. Lacy, Lawrence S. Gross, Marcia K. Goin, Calvin R. Sumner, Bernard A. Fischer, MD, and Andrew E. Slaby, Journal CME’S Primary Psychiatry. 15(11):67-71, 2008
62. Joy JA, Julius RJ, Akter R., Baron D., Assessment of ADHD Documentation from Candidates Requesting Americans with Disabilities Act (ADA) Accommodations for the National Board of Osteopathic Medical Examiners COMLEX Exam. Journal of Attention Disorders. 14(2): 104-8, April 2009
63. G. Stahler, J. Mennis, R. Cotlar, D. Baron The Influence of the Neighborhood Environment on Treatment Continuity and Rehospitalization for Dually Diagnosed Patients Discharged from Acute Inpatient Care. Am J Psychiatry. 166(11):1258-68, 2009
64. Baron, David, DA Quaderni Italiani di Psichiatria - Italian Journal of Psychiatry online on ScienceDirect at http://www.sciencedirect.com/science/journal/03930645. April 2009
65. Durell TM, Pumariega AJ, Rothe EM, Tamayo JM, Baron D, Williams D. Effects of open-label atomoxetine on African-American and Caucasian pediatric outpatients with attention-deficit/hyperactivity disorder. Ann Clin Psychiatry 21(1):26-37, 2009
66. Baron D, Garbely J, Boyd RL, Evaluation and Management of Substance Abuse Emergencies, Clinical Focus 16(9):41-47, 2009
67. Baron DA, Foley T., Doping in Sports, Psychiatriki, 20(4):336-41, Oct. 2009
68. Baron, David Clinical Focus Managing Substance Abuse Emergencies: Group II. Psychiatry Weekly November 2, 2009, Volume 4, Number 24, PF/GG
69. Baron, David, AbolMagd S, Erfan, S, El Rakhawy, M. Personality of Mothers of Substance-Dependent Patients Dove Medical Press, Journal of Multidisciplinary Healthcare, 28(3):29-32, 2010\
70. Joy JA, Julius RJ, Akter R., Baron DA., “Assessment of ADHD Documentation from Candidates Requesting Americans With Disabilities ACT (DAD) Accommodations for the National Board of Osteopathic Medical Examiners COMLEX Exam”, J Atten Disorder. 14(2):104-8, 2010
71. Rawls SM, Baron DA, Kim J. Beta-Lactam antibiotic inhibits development of morphine physical dependence in rats. Behavioural Pharmacology.;21(2):161-4, 2010
72. Baron DA. The gold medal face of ADHD. J of Attention Disorders. 13(4):323-4, 2010
73. Rawls SM, Zielinski, M., Patel H, SaCavage S., Baron, D., A beta-lactam antibiotic reduces morphine analgesic tolerance in rats through GLT-1 transporter activation. Drug and Alcohol Dependence. 107.2-3::261-3, Mar 2010
74. Langford D, Baron D, Joy J, Del Valle L, Shack J. Contributions of HIV infection in the hypothalamus and substance abuse/use to HPT dysregulation. Psychoneuroendocrinology 36(5):710-9, 2011
75. Sato K, Awasaki Y, Kandori H, Tanakamaru ZY, Nagai H, Baron D, Yamamoto M. Suppressive effects of acid-forming diet against the tumorigenic potential of pioglitazone hydrochloride in the urinary bladder of male rats. Toxicology & Applied Pharmacology. 251(3):234-44, 2011
76. Baron DA, Pato MT, Cyr RL. “Treatment of adults with attention-deficit/hyperactivity disorder”, J Am Osteopath Assoc.111(11):610-614, 2011
77. Rasmussen, BA, Baron, DA, Kim JK, Unterwald EM, Rawls, SM, Beta-Lactam antibiotic produces a sustained reduction in extracellular glutamate in the nucleus accumbens of rats. Amino Acids. 40(2):761-4, 2011
78. Langford D, Baron D, Joy J, Del Valle L, Shack J, Contributions of HIV infection in the hypothalamus and substance abuse/use to HPT dysregulation, Psychoneuroendocrinology , 36(5):710-9, 2011
79. Mennis, J, Stahler GH, Baron D. Geographic Barriers to Community-Based Psychiatric Treatment for Drug Dependent Patients. Ann Assoc American Geographers, 102(5):1093-1103, 2012
80. Baron, DA, Review of The Science of the art of psychotherapy, 18(6): 467-468, 2012
81. Lacy BW, Baron DA, Goin MK, Gross LS., Slaby AE, Sumner CR, Doing nothing is doing something: primary care antidepressant treatment in the era of FDA boxed warnings. J Am Osteopath Assoc. 113(2): 117-9, 2013
82. Stahler, Gerald J, Mennis, Jeremy, Baron, David A, Geospatial Technology and the “Exposome”: New Perspectives on Addiction. American Journal of Public Health, 103(8):1354-1356, 2013
83. Baron, D., Anxiety in Primary Care (published Turkish), Psikeart. 4-5, March 2014
84. Blum, K., Simpatico, T., Badgaiyan, RD., Baron, D., Femino, J., Gold, M., Should the United States Government Repeal Restrictions on Burprenorphine/Naloxone in the short-Term not the long-Term? (in press) 19
85. Kenneth Blum1, Peter K. Thanos, Marlene Oscar-Berman, Marcelo Febo, David Baron, Rajendra D. Badgaiyan, Eliot Gardner1, Zsolt Demetrovics1, Claudia Fahlke, Mark S. Gold, Dopamine in the Brain: Hypothesizing Surfeit or Deficit Link to Reward and Addiction
86. Blum K, Febo M, Thanos PK, Baron D, Fratantonio J, Gold M, Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as Paradigm Shift: Dopamine for Dinner? DOI 10.1007?s12035-015-9110-0
87. Blum K, Febo M, Thanos P K, Baron D, Fratantonio J, Gold M, Clinical Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner? Mol Neurobiol, Mol Neurobiol 52-1862-1869 2015